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1. Introduction
Long ago, humanity has sought alternatives to replacing living tissue, mainly due to birth
defects, disease and accidents, using synthetic or natural substances as substitutes, best known
as biomaterials. Thus, tissue engineering has emerged, a new and challenging field of modern
medicine, which aims at recreating tissues and/or healthy organs to replace missing or diseased
body parts [1].
Regenerative medicine which used medical devices and grafts underwent some changes in
recent years, changing to a more biological approach, with use of specific biodegradable
bioactive and supports (scaffolds) with cells and / or biological molecules to create a functional
tissue repair in a diseased or damaged site. Thus, some newer and inter-related strategies are
being used for the regeneration of tissues such as cell injection, cell induction and cells seeded
in scaffolds (cell seeded scaffold) (detailed later in this chapter) [2]. These approaches depend
on the use of one or more key elements, such as cells, growth factors and matrix for guiding
tissue regeneration [3].
The technique used to obtain tissues (tissue engineering) is the regeneration of organs and
living tissues, through recruitment of the patient's own tissue, which are dissociated into cells
and cultured on synthetic or biological carriers, known as scaffolds (scaffolds, three-dimen‐
sional matrices, structures, etc.) and then being reinserted into the patient. As a multidiscipli‐
nary science, the work involves knowledge of the areas of biology, health sciences and
engineering and materials science [4, 5].
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Thus, one important step for reconstruction of an organ or tissue is the scaffold selection to the
cells, which must take into consideration the type, location and extent of injury. The scaffold
structure provides mechanical support to the cell growth and allows transport of nutrients,
metabolites, growth factors, and other regulatory molecules, both towards the extracellular
environment to the cells, as in the opposite direction [6]. When prepared with bioresorbable
polymeris, scaffolds, the scaffolds have specific implementation strategies [7].
After a degradable polymer is identified as a possible candidate for applications in tissue
engineering, it must be used for manufacturing a porous scaffold [8, 9, 10, 11]. In this case, two
methods are required for proper material manufacture: 1) a method that forms the polymer
into a bulk material; 2) a method to make porous such material [12]. The optimal method of
manufacturing depends in part on the chemical nature of the polymer. Long, saturated and
linear polymers such as PLG are typically formed into bulk materials by entangling the
individual polymer chains to form a loosely bound polymer network. Polymer chain entan‐
glement is often achieved by casting the polymer within a mold. The advantage to these
methods is that they are relatively simple. However, since the material is elastic solid only
because of entangled polymer chains, the material is generally lacking significant mechanical
strength. This disadvantage is difficult to overcome without altering the chemical structure of
the polymer [12].
Another method to form a bulk material from a linear polymer involves forming chemical
bonds between polymer chains, known as polymer cross linking [13, 14]. Cross linking is most
often performed between unsaturated carbon-carbon double bonds, and thus this moiety, or
a similarly reactive one, is required to exist on somewhere along the polymer chain. An
initiation system, typically either radical or ionic, is also needed to promote cross-linking. The
initiator system is combined with the polymer and, in response to a signal such as heat, light,
a chemical accelerant, or simply time, the initiator forms species that propagate cross-linking.
As these polymers are formed into bulk materials by covalent cross-linking, they typically
posses significant mechanical strength. Furthermore, their ability to cure in response to an
applied signal allows these materials to be injected into the defect site and cure in situ. The
major disadvantage of crosslinked materials is that the growing complexity of the material, in
terms of the number of components and presence of a chemical reaction, often leads to
problems with cytotoxicity and biocompatibility [12].
In this context, biomaterials are extremely important for tissue regeneration process, and can
be defined as any substance constructed in such a way that, alone or as part of a complex
system, is used for driving, through the control of interactions with components a living
system, the course of a diagnostic or therapeutic procedure, whether in humans or animals [15].
In recent decades, biomaterials have been used to repair tissue function, such as metal
implants, without concern for its effect on local tissues or on the cells. Thus, polymers and
other synthetic materials with biological properties were then developed. More recently,
degradable and natural scaffolds, considered a breakthrough for regenerative medicine have
been used. Thus, there was an evolution of the use of biomaterials that simply replaced the
damaged tissue, to others more specific, allowing the development in three dimensions of a
tissue regenerated in full operation and structurally acceptable [2].
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To use a material with the purpose of replacing a part of the body or induce the formation of
a given tissue, a range of tests and assessments are necessary to establish the potential benefits
and possible adverse effects that the material may have. Thus, biomaterials should have the
following characteristics: not inducing thrombus formation as a result of contact between the
blood and the biomaterial, not inducing adverse immune response, not being toxic or carci‐
nogenic, not disturbing the blood flow, and not producing chronic or acute inflammatory
response that prevents the proper differentiation of adjacent tissues [16].
In other words, the biomaterial must be fully biocompatible, that is, must have the ability to
perform its desired function with respect to a medical therapy without inducing any undesir‐
able local or systemic effect to the body; but generating cellular and tissue responses beneficial
in that specific situation, and optimizing the clinically relevant responses of that therapy [15].
However, it is worth noting that despite the material having been considered inert for a
considerable time, it was suggested that they may induce physical and chemical changes after
deployment. Thus, before a biological perspective, no material can be considered in fact inert.
2. Strategies for formation and development of tissues
The strategies employed for tissue engineering can be classified into three main classes:
conductive or inductive approaches and cell transplantation.
The conductor/conductive approaches using biomaterials in a passive manner to facilitate the
growth or regeneration capacity of existing tissue such as, for example, use of membranes or
barriers for applied regeneration, adhesion molecules, growth factors, etc. in cases of perio‐
dontal diseases [1, 17, 18] or dental implant itself, which is a relatively simple implementation
because the apparatus used does not include the use of living cells or other diffusible biological
signals [19]. In the conductive techniques is usually accomplished the neoformation of
periodontal complex structures, including cementum and periodontal ligament fibers [1]. The
periodontium regeneration is the first engineering technology for dental tissue [17].
In 1965, Urist [20] demonstrated for the first time that the new bone formation could occur in
a non-mineralized site after implantation of powder bone. This discovery led to the isolation
of the active ingredients (specific growth factors - proteins) from bone powder, and the cloning
of the genes encoding these proteins. These concepts have been used by many companies for
production and expansion of these factors on a large scale [21]. Another method employed is
the induction type or inductive approach, which involves the activation of cells near the defect
site with specific biological signals that stimulate proliferation and assist in regeneration and
repair of tissues by use of materials such bone morphogenetic proteins (BMPs) [20, 22] with
promising results for supplementation therapies and the regeneration and bone repair in cases
of fractures and periodontal disease [1].
In other words, an alternative approach is the use of diffusible growth factors, and consists of
placing specific extracellular matrix molecules on a scaffold to allow the tissue growth. These
molecules have the ability to direct or induce the function of cells already present in this
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location, and in consequence, promoting the formation of a tissue type or a particular desired
structure at the location [23].
For the tissue induction can be clinically successful, it is necessary that the biologically active
factors are delivered properly to the desired location and in the correct dose for the time period
necessary. Typically, many such proteins have a short half-life in the body, but must be present
for a long time to be effective. Doctors and researchers have shown these concerns so far by
offering large doses of protein at the sites of interest [19]. The most recent research involves
the development of a controlled release system of these proteins (inducing factors) [24] and,
with the advent of genetic engineering in current biotechnology, a somewhat similar approach
involves transfection of a gene encoding the inducing factor, instead of delivering the protein
itself [19].
Cell transplantation is the third method, which consists of the direct transplantation of cells
grown in the laboratory [25]. This approach is a strategy whose importance is based on the
need for a multidisciplinary team for performing tissue engineering, since it requires the
physician or surgeon in charge of obtaining tissue samples by biopsy, the bioengineer, who
usually participates in manipulating the tissues in bioreactors and prepares the means
necessary for placing the cells obtained from biopsy samples, besides cell biologist, who will
apply the principles of cell biology required for multiplication and maintenance of cells in the
laboratory [1, 18, 26, 27].
Despite having different mechanisms, the three strategies for tissue formation have one
characteristic in common: the use of polymeric materials. In conducting approaches, polymer
is mainly used as a membrane barrier for exclusion of particular cells that can disturb the
regenerative process. In the inductive approaches, these materials act as a carrier for delivery
of proteins (e.g., BMP) or the DNA encoding the protein [24, 28]. With regard to approaches
used to achieve control of the dose and bioavailability of biodegradable polymer carriers
enable localized and sustained release of inductive molecules. The dose rate and the molecule
to be delivered are controlled generally by gradual breakdown of the vehicle [24].
These delivery vehicles are often used in cell transplantation approaches. However, in this
approach the vehicle serves as a carrier of intact cells and even partial tissues [1].
Besides acting as vehicles for the simple delivery of cells, the vehicles also serve as scaffolds
to guide new tissue to grow in a predictable way from the interaction between cells or
transplanted tissue and host cells. The collagen derived from animal sources, and synthetic
polymers of lactic acid and glycolic acid are the main absorbable materials used for tissue
repair in three types of approaches. The collagen is degraded by cells in the tissue during its
development, whereas the synthetic polymers are degraded into natural metabolites of lactic
acid and glycolic acid by the water action at the implant site. From the development and
innovation of biotechnology in tissue engineering various new materials are also being
developed for these applications, such as injectable materials that enable a minimally invasive
delivery of inductive molecules or transplanted cells [1].
Below (Figure 1), a schematic view of the three types of approaches in tissue engineering:
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 Figure 1. Schematic representation of the three main approaches for tissue rebuilding in tissue engineering in jaw: I) by
the conductive method where use is made of a barrier that is able to exclude connective tissue cells that may interfere
with the regeneration process and at the same time enables the desired host cells to populate the site to be regenerated.
II) by the inductive method, in which a scaffold of the biodegradable polymer is used as a delivery vehicle for growth
factors and / or genes encoding this factor in the desired location. As the polymer is being degraded, the growth factor
is being released gradually. III) by the strategy of cell transplantation, which uses a delivery vehicle, similar to that
used in an inductive approach, with the goal of transplanting cells and partial tissues to the place where we want to
regenerate tissue. In this approach can be transplanted only tissues or cells previously formed in the laboratory from
scaffolds.
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Tissue engineering seeks solutions for the regeneration of various tissues associated with the
oral cavity, such as, bones, cartilage, skin and oral mucosa, dentin and dental pulp, and salivary
glands. But in fact, this science will probably have its most significant impact in dentistry
through bone reconstruction and regeneration. The fact that cell transplantation approaches
may offer the possibility of pre-formation of bone structures of large dimensions (for example,
full jaw), which may not be possible to use the other two strategies, makes it the most important
approach in the engineering scope for bone tissue formation [1] (Figure 2).
Figure 2. Schematic representation of the advances in tissue engineering to regenerate part of the jaw by means of cell
transplantation. A scaffold consisting of biodegradable polymer in the shape of half of the jaw is built (I). Thereafter,
bone precursor cells are seeded on the polymer (beige dots) and stimulated to grow in a bioreactor (II). The scaffold
will then be gradually degraded, while facilitating growth of jaw-shaped bone (III) (Scheme adapted from [1].
Thus, the tissue repair from the in vitro tissue engineering requires the use of cells to comple‐
tion and production of similar matrix to the native tissue. The main successful developments
in this field have been using the transplant of primary cells taken from patient and used in
combination with scaffolds to produce the required tissue to re-implant. However, this
strategy has limitations due to the invasive nature of how the cells are removed. Thus, attention
has turned to the use of stem cells, including embryonic stem cells and mesenchymal cells
derived from bone marrow. In addition to being able to turn into all body tissues, these cells
have the capability and advantage of being maintained in culture for long periods, thus having
the potential to obtaining large amounts of cells to tissue. The extraordinary ability of these
pluripotent cells is linked to their ability to form teratoma [29]. Besides the potential to
differentiate into osteoblasts, the possibility of rejection of these cells is greatly reduced.
In cell transplantation, these units can be directly transplanted to the desired location or they
may be cultured in the laboratory on scaffolding. In this case, those cells are stimulated to lay
the groundwork matrix to produce a tissue for transplantation [29].
Currently, several products can be used to achieve tissue regeneration or reconstruction. These
options are divided according to the approach to be used (Inducing, conductive or cell
transplantation) as shown in the scheme below (Figure 3) adapted from [19].
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Figure 3. Products used for bone tissue repair in different types of approaches (Inducing, or conductive cell transplan‐
tation) (Adapted from de Kumar, Mukhtar-Un-Nisar and Zia, 2011) [19].
3. Importance of tissues for maxillofacial complex
The maxillofacial complex can be subjected to processes of physical, chemical and biological
nature, which usually determine from minor tissue losses to the involvement of large areas of
structures of this complex. In this context, dentistry has been explored new technologies in
order to change this reality, adapting to new concepts, scientific innovations that include
research on stem cells, tissue engineering, and molecular biology techniques, as tools to
stimulate regeneration or replacement of damaged tissue by tissue engineering.
Considering the scenario of new technologies, however, still in 2001 it was asked: "What impact
could have this engineering in dentistry?" And "What maxillofacial tissues have potential or
are important for that engineering?" According to Kaigler and Mooney (2001) [1], at that time
the answer to the first question was still being formulated, since the engineering probably
would have a revolutionary effect on the field of Dentistry, once almost all types of tissues in
the maxillofacial complex could have potential for engineering. Currently, reality has changed
significantly due to which the tissue engineering has wide application to many different tissue
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types associated with the oral cavity, including bone, cartilage, skin, oral mucosa, dentin and
dental pulp, and salivary glands.
As previously mentioned, inductive, conductive and cell transplantation strategies, which
represent the most used techniques in tissue engineering, are of importance to typically use
different material components in order to achieve the goal of regeneration and / or replacement
of damaged tissues.
Absolutely, all tissues of the maxillofacial complex are important for its proper functioning,
playing a crucial role also in facial aesthetics. Thus, some comments are required about the
major oral tissues and their importance for tissue engineering.
With respect to bone, it can be said that tissue engineering has had a greater impact in dentistry,
particularly with regard to bone regeneration. Bone loss associated with trauma, diseases or
disorders can currently be handled through the use of biomaterials for auto-grafts, allografts
or synthetic, morphogenetic proteins (BMPs) and growth factors. It is reported that even
though these biomaterials stimulate, replace and / or restore the stability and function of tissues
in a reasonably sufficient manner, there are still limitations in their use, which is of importance
for research is increasingly carried out using the three main strategies of tissue engineering in
order to optimize the mechanisms of regeneration in bone areas compromised by various
damaging agents [1, 28, 30].
The importance of cartilage tissue to tissue engineering of structures of the maxillofacial
complex lies in the possibility of reconstruction of craniofacial chondromatosous structures,
the design of polymeric structures with defined mechanical and degradative properties that
can serve as a support structures for cartilage cell proliferation of temporomandibular or
intranasal joints if compromised by trauma or degenerative diseases. One of the limitations of
the use of cartilage tissue in tissue engineering is due to its limited capacity for regeneration
and lack of inductive molecules to the proliferation of their cells; thus it is one of the tissues of
great interest among researchers to develop envisaging bioengineering techniques for
transplanting of cartilage cells [1, 31, 32].
Researches have been and continue to be focused on the production of dentin and dental pulp
by the use of tissue engineering strategies. The importance of these tissues for this engineering
is associated with the possibility to replace material lost by carious processes. There is evidence
that odontoblasts, even lost due to caries, it would be possible to induce the formation of new
pulp tissue cells by tissue engineering based on the use of certain biomolecules stimulating or
inducing odontoblast proliferation and / or nerve cells, and these new odontoblasts, in turn,
could synthesize new dentin material. Furthermore, it is suggested that the tissue engineering
of the dental pulp itself may be possible by using techniques of cultured fibroblasts in synthetic
polymer matrices [33, 34, 35, 36, 37].
One of the most exploited tissues in research of tissue engineering in dentistry is the epithelial
lining of the oral mucosa with significant advances in the use of these tissues in regeneration
and / or replacement of structures of the oral mucosa damaged by various aggressors. Recently,
the introduction of 3D reconstruction of the oral mucosa has significantly impacted the
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approaches to biocompatibility evaluation of tissues and materials to replace and / or regen‐
erate oral soft tissues [2, 38, 39, 40].
One of the most challenging areas of genetic engineering applied to the structures of the
maxillofacial complex is the replace of function of salivary glands, since these tissues play
important roles in mastication, phonation and protection of hard and soft tissues of the mouth
by saliva production. In this context, we study the possibility of salivary gland cells trans‐
plantation or creating a replacement for compromised glandular structures through the use of
artificial salivary glands consisting of a polymer tube coated with salivary epithelial cells [41].
The success importance of future tissue engineering for these tissues might represent the
possibility of new and more effective approaches to the treatment of conditions associated with
loss of function of the salivary glands, including dysphagia, dysgeusia, rampant caries and
mucosal infections [1].
Regarding the possibility of reproducing teeth, there are numerous growth factors involved
in the development of dental organs and biological processes involved in odontogenesis are
quite complex, reason why we still cannot form a complete tooth; however, some studies have
shown the enamel and dentin formation from stem cells isolated from dental pulp [42, 43]. The
replacement of missing teeth by tissue engineering in humans is still being researched, but
with a real possibility of application in the future.
4. Biomaterials used in craniofacial tissue regeneration
Biomaterials play a crucial role in tissue engineering. They are used for the manufacture of
supports or matrices which allow a suitable microenvironment for optimal cell regeneration.
Biomaterials for constructing scaffolds can be natural/synthetic and rigid/non rigid. Natural
biomaterials offer good cellular compatibility i.e. ability to support cell survival and function
thereby enhancing the cells’ performance, and biocompatibility. Their disadvantages include
source variability, immunogenicity, if not pure, limited range of mechanical properties and
lack of control over pore size. Unlike natural biomaterials, synthetic biomaterials can be
manufactured in unlimited supply under controlled conditions, are cheaper and can be
tailored to obtain desired shape, cell differentiation properties and mechanical and chemical
properties especially the strength, pore characteristics and degradation rate suited for intended
applications. However, synthetic biomaterials lack cell adhesion sites and require chemical
modifications to improve cell adhesion
During the last century, various natural or synthetic biomaterials have been used for the
manufacture of supports for tissue engineering (fabrication of tissue engineering scaffolds)
such as metals, ceramics and polymers. However, metals and ceramics are not biodegradable
and its processing is limited, which prevents their application as effective supports (scaffolds)
for tissue regeneration. Thus, the polymers has been the most commonly used because they
have some important characteristics for tissue regeneration such as biodegradability, porosity,
large surface area and ease of processing, among others [44, 45].
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There are two types of polymers: natural and synthetic [46, 47]. The main biodegradable
synthetic polymers include polyesters, polyanhydride, polyfumarate, polycaprolactone,
polycarbonate and polyorthoester [7, 48]. The polyesters such as poly (glycolic acid) (PGA),
poly (lactic acid) (PLA), and their copolymer of poly [lactic-co-(glycolic acid)] (PLGA) are most
commonly used for tissue engineering. The natural polymers include proteins of natural
extracellular matrices such as glycosaminoglycan, collagen, alginic acid and chitosan etc [49,
50]. These polymers of natural origin are biodegradable and possess known cell-binding sites.
However, they have some disadvantages such as the level of immunogenicity and speed of
degradation.
The tissue regeneration from cells transplanted into a polymer scaffold is summarized in
Figure 4.
Figure 4. Schematic figure illustrating the steps performed in the laboratory for tissue regeneration from the use of trans‐
planted cells stimulated to grow on biomaterials. It is necessary to understand the importance of biomaterial to perform
this technique. It can be natural or synthetic and should meet the requirements of biocompatibility and other features al‐
ready mentioned in this chapter. It is also important to realize the multidisciplinarity involved in this process. The physi‐
cian is needed in order to perform the tissue biopsy to remove the cells (I). This tissue/cell is then taken to the laboratory
to be multiplied several times. Thereafter, the use of principles of cell biology, such as growth factors (II) to stimulate the
cells to grow and maintain their functions will be necessary. It is also required the involvement of engineers for manufac‐
turing matrices of biodegradable polymers (III) and the bioreactor (IV). When cells grow in appropriate number, they are
seeded on the polymer scaffold. The tissue is then allowed to grow in the bioreactor until the time of transplantation by
clinical surgeon. Biomaterials can be used to stimulate the growth of several types of tissues, e.g. bone, cartilage or skin.
After the appropriate development, the tissue is transplanted and the area is regenerated.
Other extracellular matrices used as scaffolds include fibrin and fibrinogen. [51, 52, 53].
According to some studies, both can induce angiogenesis during tissue regeneration [54, 55,
56]. Chitosan is a derivative of chitin, a natural biopolymer which is biocompatible, biode‐
gradable, antimicrobial and possesses tissue healing and osteoinductive effects. It has the
ability to bind to growth factors, glycosaminoglycans and DNA and can be easily processed
into membranes, gels, nanofibres, beads, scaffolds and sponges. Because of these properties,
chitosan gel alone or in combination with demineralized bone matrix/collagenous membrane
is quite promising in periodontal regeneration [57].
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Considering the bone tissue engineering, porous scaffolds are designed to support the
migration, proliferation, and differentiation of osteo-progenitor cells and aid in the organiza‐
tion of these cells in three dimensions. These scaffolds may be made from a wide variety of
both natural and synthetic materials. The naturally derived materials include cornstarch-based
polymers, [58] chitosan [59, 60] collagen, [61] and coral [62, 63]. Among these materials, the
coral has been shown to be an effective clinical alternative to autogenous and allogenous bone
grafts [64, 65].
Examples of synthetic materials include calcium phosphates [66, 67] and organic materi‐
als such as poly (phosphazenes), [68] poly (tyrosine carbonates), [69] poly (caprolactones)
[70], poly (propylene fumarates) [71], and poly (α-hydroxy acids) [72, 73]. Composites of
inorganic  and organic  materials  have also been successfully  used to  create  scaffolds for
bone  grafts  [74,  75].  Poly  (α-hydroxy  acids)  are  the  most  commonly  used  polymeric
materials for the creation of tissue-engineering scaffolds for bone. The most common of the
poly (α-hydroxy acids) are poly (glycolic acid), poly (lactic acid) (PLA), and copolymers of
poly (lactic-co-glycolic acid) (PLGA). These materials are readily metabolized and excret‐
ed when degraded by the body [44].
5. Challenges and future prospects
Tissue engineering is an emerging technology with potential application in various medical
fields. The main focus of recent research is the development of techniques for manipulating
stem cells, aiming at the achievement of restorative treatments of injured and/or lost tissues
and organs. Apart from stem cells, bioengineering requires the presence of factors that allow
their proliferation in a microenvironment closer to tissue reality, including the extracellular
matrix and growth factors. The biomaterials, in turn, are necessary for serving as porous
scaffold upon which tissue regeneration is set. As knowledge is acquired with respect to stem
cells and biomaterials, the potential for treating diseases may extend beyond the craniofacial
region of the body. However, the mechanisms of action of these biotechnologies are not yet
fully understood and offer a promising future, so that research is needed to apply them
clinically.
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